$57.720
-1.605 (-2.78%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
CRSP 相似圖表分析預測
Alphio's CRSP stock price prediction model matches the current CRISPR Therapeutics AG tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $57.11 (-1.06%). The 1-week path is $58.30 (+1.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 CRISPR Therapeutics AG 股票嗎？
CRISPR Therapeutics AG (CRSP) is a good buy right now due to its recent positive trial results for CTX310, which showed a 79% reduction in ANGPTL3 levels and significant decreases in triglycerides and LDL cholesterol. The stock is currently priced at $57.72, with a forward P/E ratio of 23.36, indicating potential for growth as the company expands its pipeline. However, the main risk is the high insider selling activity, which has increased by 476.16% over the last month, suggesting caution from insiders.
CRSP 股價於 Friday 收在 $57.72，此前下跌 -2.78%
CRISPR Therapeutics AG (CRSP) last closed at $57.72, losing -2.78%. These facts feed the 1-day and 1-week CRSP price prediction above.
分析師一致預期
CRISPR Therapeutics AG（CRSP）：買進 3、持有 3、賣出 0。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
CRISPR Therapeutics AG（CRSP）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 CRSP 最接近的股票，依相似度排序。
CRSP 季節性分析
Historically the probability of a positive August return for CRSP is 52.38%. March offers the highest probability of a positive month at 61.90%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
CRSP 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Aug 2026 | $23.36 | $40.75 | $47.95 | -29.40% |
| Sep 2026 | $22.73 | $37.13 | $47.22 | -35.67% |
| Oct 2026 | $17.82 | $33.96 | $51.74 | -41.17% |
| Nov 2026 | $29.09 | $38.88 | $44.05 | -32.64% |
| Dec 2026 | $37.57 | $46.16 | $57.97 | -20.03% |
2026 年，CRISPR Therapeutics AG（CRSP）預計區間為 $17.82 至 $57.97。
CRISPR Therapeutics AG 2026 年月度預測
2026 年 Aug，CRISPR Therapeutics AG 預計均價 $40.75，最低 $23.36，最高 $47.95。
2026 年 Sep，CRISPR Therapeutics AG 預計均價 $37.13，最低 $22.73，最高 $47.22。
2026 年 Oct，CRISPR Therapeutics AG 預計均價 $33.96，最低 $17.82，最高 $51.74。
2026 年 Nov，CRISPR Therapeutics AG 預計均價 $38.88，最低 $29.09，最高 $44.05。
2026 年 Dec，CRISPR Therapeutics AG 預計均價 $46.16，最低 $37.57，最高 $57.97。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。